Demographic data of participants
| Gabapentin | Hypnotherapy | p Value* | |
|---|---|---|---|
| n=14 | n=11 | ||
| Median age | 52 (45, 63) | 56 (42, 62) | – |
| Race | |||
| Caucasian | 14 (100%) | 10 (90.9%) | 0.4 |
| African-American | 0 | 1 (9.1%) | |
| History of cancer | 11 (78.6%) | 5 (45.5%) | 0.1 |
| Tamoxifen | 6 (42.9%) | 3 (27.3%) | 0.7 |
| Antidepressant use | 3 (21.4%) | 2 (18.2%) | 1.0 |
| Baseline daily hot flashes | |||
| 1–5 | 3 (21.4%) | 1 (9.1%) | 0.8 |
| 5–10 | 8 (57.1%) | 8 (72.7%) | |
| >10 | 3 (21.4%) | 2 (18.2%) | |
*Fisher's exact test.